Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoprolol succinate in heart failure with preserved ejection fraction
ChiCTR-TRC-08000144Phase 4Completed
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of metoprolol in heart failure with preserved ejection fraction (HFpEF) (2 arms), sponsored by Zhongshan Hospital, Fudan University. Started Jan 2008; status: completed.
02
Drugs
metoprolol
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on ChiCTR-TRC-08000144.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000144.